Royalty Pharma plc (RPRX)
Market Closed
17 Jul, 20:00
$
58. 18
-0.35
-0.598%
$
23.94B Market Cap
11.13 P/E Ratio
0.84% Div Yield
2.54M Volume
3.8 Eps
$ 58.53
Previous Close 
Want to track RPRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | 1.18 | - |
| | | 1.5 | 0.38 |
| | | - | - |
| | | 1.04 | - |
| | | 0.95 | 1.06 |
| | | 1.05 | 1.15 |
| | | 0.93 | 1.01 |
| | | 0.99 | - |
| | | 0.98 | 0.98 |
| | | 1.01 | 1.15 |
| | | 0.76 | 0.79 |
| | | - | - |
RPRX Earnings Reports FAQ
What is the earnings per share (EPS) for RPRX?
The current EPS is 3.8.
What is the company's earnings growth rate?
Over the past 9 years, the earnings growth rate has been approximately -30.64%, reflecting the RPRX's performance and NASDAQ (NGS) market conditions.
When is the next earnings release date?
Royalty Pharma plc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Royalty Pharma plc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for RPRX at this time, as Royalty Pharma plc has no recent EPS data to calculate it.
